Get the Stockscreener App
1.41
6.02%
0.08
Pre-market:
1.40
-0.01
-0.71%
Tenaya Therapeutics Inc stock is traded at $1.41, with a volume of 1.89M.
It is up +6.02% in the last 24 hours and up +2.17% over the past month.
Tenaya Therapeutics Inc is a preclinical stage biotechnology company focused on discovering, developing, and delivering curative therapies that address the underlying drivers of heart disease. It is advancing product candidates from three product platforms: gene therapy, cellular regeneration and precision medicine.
See More
Previous Close:
$1.33
Open:
$1.31
24h Volume:
1.89M
Relative Volume:
0.52
Market Cap:
$234.77M
Revenue:
-
Net Income/Loss:
$-111.13M
P/E Ratio:
-1.0682
EPS:
-1.32
Net Cash Flow:
$-91.53M
1W Performance:
+3.68%
1M Performance:
+2.17%
6M Performance:
+167.70%
1Y Performance:
-58.77%
1-Day Range:
$1.305
$1.42
1-Week Range:
$1.21
$1.425
52-Week Range:
$0.36
$4.01
Tenaya Therapeutics Inc Stock (TNYA) Company Profile
Name
Tenaya Therapeutics Inc
Sector
Industry
Phone
415-865-2066
Address
171 OYSTER POINT BLVD., SUITE 500, SOUTH SAN FRANCISCO
Compare TNYA with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
TNYA
Tenaya Therapeutics Inc
|
1.41 | 221.45M | 0 | -111.13M | -91.53M | -1.32 |
|
VRTX
Vertex Pharmaceuticals Inc
|
457.26 | 117.50B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
722.83 | 76.06B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
464.56 | 62.53B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
916.31 | 56.75B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
205.04 | 44.10B | 447.02M | -1.18B | -906.14M | -6.1812 |
Tenaya Therapeutics Inc Stock (TNYA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jun-10-24 | Initiated | William Blair | Outperform |
| Nov-30-23 | Initiated | Leerink Partners | Outperform |
| Jun-15-22 | Initiated | H.C. Wainwright | Buy |
Tenaya Therapeutics Inc Stock (TNYA) Latest News
Tenaya Therapeutics Stock: Risky But Promising Cardiac Gene Platform (NASDAQ:TNYA) - Seeking Alpha
Can Tenaya Therapeutics Inc. stock resist market sell offs2025 Top Gainers & High Conviction Investment Ideas - Newser
Tenaya Therapeutics, Inc. (NASDAQ:TNYA) Receives Consensus Recommendation of "Moderate Buy" from Brokerages - MarketBeat
Will Tenaya Therapeutics Inc. stock return to pre crisis levelsEarnings Overview Report & Safe Entry Point Identification - Newser
Why Tenaya Therapeutics Inc. stock is considered a top pickEarnings Summary Report & Long-Term Growth Plans - Newser
Tenaya Therapeutics (TNYA) Stock Analysis Report | Financials & Insights - Benzinga
Will Tenaya Therapeutics Inc. stock benefit from sector rotationTake Profit & Daily Growth Stock Investment Tips - Newser
Is Tenaya Therapeutics Inc. stock attractive for hedge fundsMarket Movers & Expert Approved Trade Ideas - BỘ NỘI VỤ
Top 3 Insider Stock Buys in March-Are They Still Good in April? - MSN
How geopolitical tensions affect Tenaya Therapeutics Inc. stockJuly 2025 Spike Watch & Low Risk Profit Maximizing Plans - newser.com
Will Tenaya Therapeutics (NASDAQ:TNYA) Spend Its Cash Wisely? - Yahoo Finance
How supply chain issues affect Tenaya Therapeutics Inc. stock - newser.com
How resilient is Tenaya Therapeutics Inc. stock in market downturnsIPO Watch & Weekly Watchlist for Hot Stocks - newser.com
Should you wait for a breakout in Tenaya Therapeutics Inc.Breakout Watch & Safe Capital Investment Plans - newser.com
Tenaya Therapeutics SVP, finance Higa sells $1.8k in stock By Investing.com - Investing.com Australia
Tenaya therapeutics CMO Tingley sells $3826 in stock By Investing.com - Investing.com UK
Tenaya therapeutics CEO Ali Faraz sells $4,157 in stock By Investing.com - Investing.com South Africa
Tenaya Therapeutics SVP, finance Higa sells $1.8k in stock - Investing.com India
Tenaya Therapeutics Inc. (TNYA) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Tenaya Therapeutics Inc. stock chart pattern explained2025 EndofYear Setup & Intraday High Probability Alerts - newser.com
Trend analysis for Tenaya Therapeutics Inc. this weekEarnings Risk Summary & Growth Focused Stock Reports - newser.com
Is Tenaya Therapeutics Inc. stock positioned well for digital economy2025 Valuation Update & High Conviction Buy Zone Alerts - newser.com
Can Tenaya Therapeutics Inc. rally from current levelsJuly 2025 Patterns & Technical Confirmation Trade Alerts - newser.com
When is the best time to exit Tenaya Therapeutics Inc.July 2025 Movers & Safe Capital Growth Tips - newser.com
Weekly Rundown: Tenaya Therapeutics' gene therapy for heart condition placed on hold - Drug Discovery News
Tenaya Therapeutics, Inc. (TNYA) Shareholder/Analyst CallSlideshow (NASDAQ:TNYA) 2025-11-14 - Seeking Alpha
Tenaya Therapeutics Inc Stock (TNYA) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.10%
1.10%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):